Maxalt RPD

Medicinal product

(Invented) name

Maxalt RPD

Active substance (s)

Rizatriptanas

Strength

10 mg

Pharmaceutical form

geriamasis liofilizatas

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N02CC04, Rizatriptan

Marketing authorisation holder

Tojaris projektai, UAB, Lietuva

Date of authorisation

2026-10-07

Date of renewal

Documents

3644_Maxalt RPD 10mg_ger_liof_PL_2026-10-07.docx

3644_Maxalt RPD 10mg_ger_liof_PZ_2026-10-07.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Geriamajame liofilizate yra	1 vnt.
Rizatriptanas	10 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
122488	108598	1108598	lizdinė plokštelė	N3		Receptinis	LT/L/26/3644/001	Netiekiama	-	-	No	-	-	Download
122489	108599	1108599	lizdinė plokštelė	N6		Receptinis	LT/L/26/3644/002	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2026-10-07	Registruotas